Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Heda purchases HEAB
Mandate

Heda purchases HEAB

November 08, 2018 M&A

Vinge has advised Hedask Skandinavien (Heda) in conjunction with the acquisition of HEAB Stängsel.

Heda is a leading company in Sweden within the installation and maintenance of systems for area protection and area security focusing on high security. HEAB delivers fencing facilities and systems for exterior security, among other things, to companies, property companies and municipal organisations.

Vinge’s team consisted of Johan Winnerblad, Johanna Wiberg, Stina Bengtsson and Tove Lövgren Frisk.
 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026